Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hypocalcemia AND ("QT" OR Torsad*):

Search results

Items: 1 to 20 of 171

1.

Effects of Altered Calcium Metabolism on Cardiac Parameters in Primary Aldosteronism.

Lim JS, Hong N, Park S, Park SI, Oh YT, Yu MH, Lim PY, Rhee Y.

Endocrinol Metab (Seoul). 2018 Dec;33(4):485-492. doi: 10.3803/EnM.2018.33.4.485.

2.

Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report.

Wu B, Wang J, Yang G, Xing C, Mao H.

BMC Nephrol. 2018 Jun 14;19(1):136. doi: 10.1186/s12882-018-0936-z.

3.

Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.

Ye J, Deng G, Gao F.

Drug Des Devel Ther. 2018 Apr 19;12:901-909. doi: 10.2147/DDDT.S160223. eCollection 2018. Review.

4.

Hypocalcemia Presenting as Life Threatening Torsades de Pointes with Prolongation of QTc Interval.

Chhabra ST, Mehta S, Chhabra S, Singla M, Aslam N, Mohan B, Wander GS.

Indian J Clin Biochem. 2018 Apr;33(2):235-238. doi: 10.1007/s12291-017-0684-z. Epub 2017 Aug 1.

PMID:
29651218
5.

Acute Onset of Quadriplegia Secondary to Hypoparathyroidism: Mimicker of AMAN Variant of GBS.

Zaidi SS, Siddiqui T, Siddiqui SJ.

J Coll Physicians Surg Pak. 2018 Mar;28(3):S23-S25. doi: 10.29271/jcpsp.2018.03.S23.

PMID:
29482695
6.

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.

Eidman KE, Wetmore JB.

Int J Nephrol Renovasc Dis. 2018 Feb 5;11:69-80. doi: 10.2147/IJNRD.S128252. eCollection 2018. Review.

7.

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.

Coppola C, Rienzo A, Piscopo G, Barbieri A, Arra C, Maurea N.

Cancer Treat Rev. 2018 Feb;63:135-143. doi: 10.1016/j.ctrv.2017.11.009. Epub 2017 Dec 6. Review.

8.

Multiple Endocrine Neoplasia Type 1.

Giusti F, Marini F, Brandi ML.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2005 Aug 31 [updated 2017 Dec 14].

9.

Risk factors for QTc interval prolongation.

Heemskerk CPM, Pereboom M, van Stralen K, Berger FA, van den Bemt PMLA, Kuijper AFM, van der Hoeven RTM, Mantel-Teeuwisse AK, Becker ML.

Eur J Clin Pharmacol. 2018 Feb;74(2):183-191. doi: 10.1007/s00228-017-2381-5. Epub 2017 Nov 22.

PMID:
29167918
10.

The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.

Demirtas D, Bilir C, Demirtas AO, Engin H.

Clin Cases Miner Bone Metab. 2017 Jan-Apr;14(1):35-39. doi: 10.11138/ccmbm/2017.14.1.035. Epub 2017 May 30.

11.

Methadone and Corrected QT Prolongation in Pain and Palliative Care Patients: A Case-Control Study.

Juba KM, Khadem TM, Hutchinson DJ, Brown JE.

J Palliat Med. 2017 Jul;20(7):722-728. doi: 10.1089/jpm.2016.0411. Epub 2017 Feb 10.

PMID:
28186837
12.

Citrate pathophysiology and metabolism.

Monchi M.

Transfus Apher Sci. 2017 Feb;56(1):28-30. doi: 10.1016/j.transci.2016.12.013. Epub 2016 Dec 30. Review.

PMID:
28073690
13.

Hypocalcemic Cardiomyopathy and Pseudohypoparathyroidism Due to Severe Vitamin D Deficiency.

Batra CM, Agarwal R.

J Assoc Physicians India. 2016 Jun;64(6):74-76.

PMID:
27739274
14.

Severe hypocalcemia and prolonged QT interval due to denosumab in an elderly woman with rheumatoid arthritis and chronic kidney disease.

Oiwa H, Mokuda S.

Eur J Rheumatol. 2016 Sep;3(3):144-145. Epub 2016 Jan 29. No abstract available.

15.

Severe hypocalcemia mimicking ST-segment elevation acute myocardial infarction.

Kukla P, Kulik M, Jastrzębski M, Bryniarski L, Czarnecka D, Baranchuk A.

Ann Noninvasive Electrocardiol. 2017 Mar;22(2). doi: 10.1111/anec.12401. Epub 2016 Sep 7.

PMID:
27604986
16.

Ileus and Intra-Abdominal Hypertension due to Phosphate- Containing Enema.

Akyildiz B, Kondolot M, Yikilmaz A, Arslan D, Kurtoğlu S.

Indian J Pediatr. 2016 Nov;83(11):1346-1348. Epub 2016 Jun 4.

PMID:
27260148
17.

Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.

Tisdale JE.

Can Pharm J (Ott). 2016 May;149(3):139-52. doi: 10.1177/1715163516641136. Epub 2016 Apr 8. Review.

18.

Nonclinical Safety Profile of Etelcalcetide, a Novel Peptide Calcimimetic for the Treatment of Secondary Hyperparathyroidism.

Fielden MR, Dean C Jr, Black K, Sawant SG, Subramanian R, Tomlinson JE, Walter S, Zimmermann C, Griggs MW, McKeon ME, Lewis EM, Beevers C, Pyrah I.

Int J Toxicol. 2016 May;35(3):294-308. doi: 10.1177/1091581816633407. Epub 2016 Mar 2.

PMID:
26941242
19.

An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.

dos Santos LM, Guerra RA, Lazaretti-Castro M, Vieira JG, Portes Ede S, Dias-da-Silva MR.

Magnes Res. 2015 Dec;28(4):136-45. doi: 10.1684/mrh.2015.0395.

20.

Cinacalcet-associated severe hypocalcemia resulting in torsades de pointes and cardiac arrest: a case for caution.

Novick T, McMahon BA, Berliner A, Jaar BG.

Eur J Clin Pharmacol. 2016 Mar;72(3):373-5. doi: 10.1007/s00228-015-1989-6. Epub 2015 Dec 1. No abstract available.

PMID:
26621501

Supplemental Content

Loading ...
Support Center